Both in Pharmaceuticals
Precigen vs Zenas BioPharma
Over the past year PGEN returned +26.2% and ZBIO returned −9.4%; their daily moves had a correlation of 0.11.
PGEN +26.2% ZBIO −9.4%Growth of $1, one year, split-adjusted
| Metric | PGEN | ZBIO |
|---|---|---|
| Price | $5.25 | $28.38 |
| Market cap | $1.88B | $1.85B |
| Today | +2.14% | +2.75% |
| 1 month | −32.2% | +2.0% |
| 6 months | +21.2% | +36.7% |
| Year to date | +25.6% | −21.8% |
| 1 year | +26.8% | −9.2% |
| Revenue growth (YoY) | +6322.7% | — |
| Gross margin | 94.9% | 100.0% |
| Net margin | 36.5% | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | 21.9× | 1,849.7× |
| Net cash | -$55.7M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 86.6% | 55.9% |
| Short % of float | 26.1% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).